Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
New Lead Medical Technology is a leading Chinese Contract Research Organization (CRO) providing full-chain pharmaceutical R&D services. The company specializes in the development of generic drugs, innovative drugs, and complex formulations, offering services that span from drug discovery and CMC (Chemistry, Manufacturing, and Controls) to clinical trials and registration. As a comprehensive CXO service provider, New Lead supports both domestic and international pharmaceutical companies in navigating the regulatory landscape and accelerating drug time-to-market. The company operates several high-tech R&D centers and has established a strong reputation for its technical expertise in high-end formulation development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New Lead Medical Technology.